SFX by Ex Libris Inc.

Title:	Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms
Source:	Nature [0028-0836] Sanada, M yr:2009

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Heinemann, A. "Stem cell factor stimulates the chemotaxis, integrin upregulation, and survival of human basophils." The journal of allergy and clinical immunology 116.4 (2005): 820-826.
description	2.	Novo, Jos J. "A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome." Genes, chromosomes & cancer 35.1 (2002): 11-19.
description	3.	Hou, Ke-Zuo C. "[Effects of Bufalin on SYK and CBL family proteins in induction of HL-60 cell apoptosis]." zhong guo shi yan xue ye xue za zhi 17.1 (2009): 65-8.
description	4.	Hill, Z. "A Chemical Genetic Method for Generating Bivalent Inhibitors of Protein Kinases." Journal of the American Chemical Society 131.19 (2009): 6686-6688.
description	5.	Joerger AC, A.C.. "Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations." The Journal of biological chemistry 279.2 (2004): 1291-1296.
description	6.	Erlanson, Daniel A. "Fragment-Based Ligand Discovery Meets Phage Display." ACS Chemical Biology 2.12 (2007): 779-782.
description	7.	Szostak, Stephanie C W. "Aptamers selected for higher-affinity binding are not more specific for the target ligand." Journal of the American Chemical Society 128.24 (2006): 7929-37.
description	8.	Yan, H. "Rats deficient for p53 are susceptible to spontaneous and carcinogen-induced tumorigenesis." Carcinogenesis 33.10 (2012): 2001-2005.
description	9.	Bunin, Greta R. "Parental diet and risk of retinoblastoma resulting from new germline RB1 mutation." Environmental and molecular mutagenesis 53.6 (2012): 451-461.
description	10.	Ernst, T. "Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders." Nature Genetics 42.8 (2010): 722-726.
description	11.	Lauth, M. "Anti-psychotic drugs regulate Hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels." Molecular pharmacology 78.3 (2010): 486-496.
description	12.	Lavogina, D. "Bisubstrate Inhibitors of Protein Kinases: from Principle to Practical Applications." ChemMedChem 5.1 (2010): 23-34.
description	13.	Wang, W. "Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts." Proceedings of the National Academy of Sciences of the United States of America 103.29 (2006): 11003-8.
description	14.	Okram, B. "A general strategy for creating "inactive-conformation" abl inhibitors." Chemistry & biology 13.7 (2006): 779-86.
description	15.	Ghose, A. "Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery." Journal of medicinal chemistry 51.17 (2008): 5149-5171.
description	16.	DePristo, Mark A A. "Missense meanderings in sequence space: a biophysical view of protein evolution." Nature reviews. Genetics 6.9 (2005): 678-687.
description	17.	Liu, Y. "Rational design of inhibitors that bind to inactive kinase conformations." Nature chemical biology 2.7 (2006): 358-364.
description	18.	Nikoloski, G. "Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes." Nature Genetics 42.8 (2010): 665-667.
description	19.	Meyer, S. "Tethering small molecules to a phage display library: discovery of a selective bivalent inhibitor of protein kinase a." Journal of the American Chemical Society 129.45 (2007): 13812-3.
description	20.	Franzini, Raphael M. "DNA-encoded chemical libraries: advancing beyond conventional small-molecule libraries." Accounts of chemical research 47.4 (2014): 1247-55.